<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR  Phase I:  Accoustically Enhanced Airlift Bioreactor</AwardTitle>
<AwardEffectiveDate>07/01/2002</AwardEffectiveDate>
<AwardExpirationDate>03/31/2003</AwardExpirationDate>
<AwardTotalIntnAmount>100000.00</AwardTotalIntnAmount>
<AwardAmount>100000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Om P. Sahai</SignBlockName>
</ProgramOfficer>
<AbstractNarration>&lt;br/&gt;&lt;br/&gt;0214761&lt;br/&gt;McGrath&lt;br/&gt;&lt;br/&gt;This Small Business Innovative Research Project proposes to combine a novel low-frequency acoustic energy technology with an airlift bioreactor. This is expected to provide a dramatic increase in bioreactor productivity by greatly increasing mass transport.  The proposed technology will meet contemporary industry needs for a high productivity, low-shear bioreactor that can be used to economically produce a broad range of traditional and newly emerging biochemicals and bioproducts.&lt;br/&gt;&lt;br/&gt;The commercial applications of this project include the culturing of pharmaceuticals and other biochemicals  from a broad range of organisms including plant cells, mammalian cells, fungi, bacteria and yeast.&lt;br/&gt;&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>06/14/2002</MinAmdLetterDate>
<MaxAmdLetterDate>07/30/2003</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0214761</AwardID>
<Investigator>
<FirstName>Steve</FirstName>
<LastName>McGrath</LastName>
<EmailAddress>smcgrath@mr3systems.com</EmailAddress>
<StartDate>06/14/2002</StartDate>
<EndDate>07/30/2003</EndDate>
<RoleCode>Former Principal Investigator</RoleCode>
</Investigator>
<Investigator>
<FirstName>Todd</FirstName>
<LastName>McAdams</LastName>
<EmailAddress>lcfarrar@resodyn.com</EmailAddress>
<StartDate>07/30/2003</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>RESODYN CORPORATION</Name>
<CityName>BUTTE</CityName>
<ZipCode>597013005</ZipCode>
<PhoneNumber>4064975252</PhoneNumber>
<StreetAddress>130 N MAIN ST STE 600</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Montana</StateName>
<StateCode>MT</StateCode>
</Institution>
<FoaInformation>
<Code>0510402</Code>
<Name>Biomaterials-Short &amp; Long Terms</Name>
</FoaInformation>
<ProgramElement>
<Code>9150</Code>
<Text>EPSCoR Co-Funding</Text>
</ProgramElement>
<ProgramReference>
<Code>9150</Code>
<Text>EXP PROG TO STIM COMP RES</Text>
</ProgramReference>
<ProgramReference>
<Code>9181</Code>
<Text>BIOPROCESSING/BIOMOLECULAR MATERIALS</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
</Award>
</rootTag>
